276 related articles for article (PubMed ID: 25114109)
1. LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.
Sun W; Sanapala S; Henderson JC; Sam S; Olinzock J; Trent MS; Curtiss R
Infect Immun; 2014 Oct; 82(10):4390-404. PubMed ID: 25114109
[TBL] [Abstract][Full Text] [Related]
2. A Recombinant Attenuated
Singh AK; Curtiss R; Sun W
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331960
[TBL] [Abstract][Full Text] [Related]
3. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ
Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954
[TBL] [Abstract][Full Text] [Related]
4. Protection Induced by Oral Vaccination with a Recombinant
Majumder S; Olson RM; Singh A; Wang X; Li P; Kittana H; Anderson PE; Anderson DM; Sun W
Infect Immun; 2022 Aug; 90(8):e0016522. PubMed ID: 35900096
[TBL] [Abstract][Full Text] [Related]
5. An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague.
Derbise A; Cerdà Marín A; Ave P; Blisnick T; Huerre M; Carniel E; Demeure CE
PLoS Negl Trop Dis; 2012; 6(2):e1528. PubMed ID: 22348169
[TBL] [Abstract][Full Text] [Related]
6. Oral vaccination with live attenuated Yersinia pseudotuberculosis strains delivering a FliC180-LcrV fusion antigen confers protection against pulmonary Y. Pestis infection.
Singh AK; Wang X; Sun W
Vaccine; 2020 May; 38(21):3720-3728. PubMed ID: 32278523
[TBL] [Abstract][Full Text] [Related]
7. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
[TBL] [Abstract][Full Text] [Related]
8. A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection.
Galen JE; Wang JY; Carrasco JA; Lloyd SA; Mellado-Sanchez G; Diaz-McNair J; Franco O; Buskirk AD; Nataro JP; Pasetti MF
Infect Immun; 2015 Jan; 83(1):161-72. PubMed ID: 25332120
[TBL] [Abstract][Full Text] [Related]
9. Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague.
Branger CG; Fetherston JD; Perry RD; Curtiss R
Adv Exp Med Biol; 2007; 603():387-99. PubMed ID: 17966435
[TBL] [Abstract][Full Text] [Related]
10. Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague.
Sun W; Roland KL; Kuang X; Branger CG; Curtiss R
Infect Immun; 2010 Mar; 78(3):1304-13. PubMed ID: 20086087
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge.
Branger CG; Sun W; Torres-Escobar A; Perry R; Roland KL; Fetherston J; Curtiss R
Vaccine; 2010 Dec; 29(2):274-82. PubMed ID: 20979987
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague.
Kilgore PB; Sha J; Hendrix EK; Motin VL; Chopra AK
mBio; 2021 Dec; 12(6):e0322321. PubMed ID: 34872353
[TBL] [Abstract][Full Text] [Related]
13. Vaccine Potential of a Recombinant Bivalent Fusion Protein LcrV-HSP70 Against Plague and Yersiniosis.
Gupta A; Narayan B; Kumar S; Verma SK
Front Immunol; 2020; 11():988. PubMed ID: 32595634
[TBL] [Abstract][Full Text] [Related]
14. Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague.
Sanapala S; Rahav H; Patel H; Sun W; Curtiss R
Vaccine; 2016 May; 34(21):2410-2416. PubMed ID: 27060051
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis.
Daniel C; Titecat M; Poiret S; Cayet D; Boutillier D; Simonet M; Sirard JC; Lemaître N; Sebbane F
Vaccine; 2016 Nov; 34(47):5762-5767. PubMed ID: 27742220
[TBL] [Abstract][Full Text] [Related]
16. A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague.
Yamanaka H; Hoyt T; Yang X; Golden S; Bosio CM; Crist K; Becker T; Maddaloni M; Pascual DW
Infect Immun; 2008 Oct; 76(10):4564-73. PubMed ID: 18694965
[TBL] [Abstract][Full Text] [Related]
17. Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine.
Demeure CE; Derbise A; Guillas C; Gerke C; Cauchemez S; Carniel E; Pizarro-Cerdá J
Vaccine; 2019 Jan; 37(1):123-129. PubMed ID: 30467064
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague.
Sun W; Sanapala S; Rahav H; Curtiss R
Vaccine; 2015 Nov; 33(48):6727-35. PubMed ID: 26514425
[TBL] [Abstract][Full Text] [Related]
19. TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.
Lin JS; Park S; Adamovicz JJ; Hill J; Bliska JB; Cote CK; Perlin DS; Amemiya K; Smiley ST
Vaccine; 2010 Dec; 29(2):357-62. PubMed ID: 20840834
[TBL] [Abstract][Full Text] [Related]
20. A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.
Sha J; Kirtley ML; Klages C; Erova TE; Telepnev M; Ponnusamy D; Fitts EC; Baze WB; Sivasubramani SK; Lawrence WS; Patrikeev I; Peel JE; Andersson JA; Kozlova EV; Tiner BL; Peterson JW; McWilliams D; Patel S; Rothe E; Motin VL; Chopra AK
Clin Vaccine Immunol; 2016 Jul; 23(7):586-600. PubMed ID: 27170642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
